Open AccessBuilding Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase
Author(s) -
Sarah Kim,
Walter M. Yamada,
Brandon Duncanson,
Jocelyn Nole,
Stephanie Rogers,
S. Parker,
Meredith Bacci,
Nino Mtchedlidze,
Charles A. Peloquin,
Arnold Louie,
Stephan Schmidt,
George L. Drusano,
Michael Neely
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00693-21
Subject(s) - bedaquiline , moxifloxacin , tuberculosis , mycobacterium tuberculosis , regimen , pharmacology , drug , population , medicine , antibiotics , combination therapy , biology , microbiology and biotechnology , pathology , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom